91 related articles for article (PubMed ID: 18827492)
1. A treatment selection protocol for recurrent ovarian cancer patients: the role of FDG-PET/CT and staging laparoscopy.
Fagotti A; Fanfani F; Rossitto C; Lorusso D; De Gaetano AM; Giordano A; Vizzielli G; Scambia G
Oncology; 2008; 75(3-4):152-8. PubMed ID: 18827492
[TBL] [Abstract][Full Text] [Related]
2. PET/Computed Tomography Transformation of Oncology: Ovarian Cancers.
Lee EYP; Philip Ip PC; Tse KY; Kwok ST; Chiu WK; Ho G
PET Clin; 2024 Apr; 19(2):207-216. PubMed ID: 38177053
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Implementation of FDG-PET/CT and Staging Laparoscopy for Gastric Cancer in The Netherlands.
Gertsen EC; Borggreve AS; Brenkman HJF; Verhoeven RHA; Vegt E; van Hillegersberg R; Siersema PD; Ruurda JP;
Ann Surg Oncol; 2021 Apr; 28(4):2384-2393. PubMed ID: 32901312
[TBL] [Abstract][Full Text] [Related]
4. Disseminated tuberculosis during TNF-α inhibitor therapy diagnosed by positron emission tomography and mini-laparoscopy.
Hermanussen L; Brehm TT; Schmiedel S
Infection; 2023 Aug; 51(4):1181-1182. PubMed ID: 36635610
[No Abstract] [Full Text] [Related]
5. Prediction of Surgical Outcome in Advanced Ovarian Cancer by Imaging and Laparoscopy: A Narrative Review.
Pinto P; Burgetova A; Cibula D; Haldorsen IS; Indrielle-Kelly T; Fischerova D
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980790
[TBL] [Abstract][Full Text] [Related]
6. Preoperative PET/CT score can predict complete resection in advanced epithelial ovarian cancer: a prospective study.
Gu B; Xia L; Ge H; Liu S
Quant Imaging Med Surg; 2020 Mar; 10(3):743-753. PubMed ID: 32269933
[TBL] [Abstract][Full Text] [Related]
7. Advanced Ovarian Cancer: Primary or Interval Debulking? Five Categories of Patients in View of the Results of Randomized Trials and Tumor Biology: Primary Debulking Surgery and Interval Debulking Surgery for Advanced Ovarian Cancer.
Makar AP; Tropé CG; Tummers P; Denys H; Vandecasteele K
Oncologist; 2016 Jun; 21(6):745-54. PubMed ID: 27009938
[TBL] [Abstract][Full Text] [Related]
8. Minimally-Invasive Secondary Cytoreduction in Recurrent Ovarian Cancer.
Certelli C; Russo SA; Palmieri L; Foresta A; Pedone Anchora L; Vargiu V; Santullo F; Fagotti A; Scambia G; Gallotta V
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835463
[TBL] [Abstract][Full Text] [Related]
9. The current role of secondary cytoreductive surgery for recurrent ovarian cancer.
de Bree E; Michelakis D; Anagnostopoulou E
Front Oncol; 2022; 12():1029976. PubMed ID: 36338689
[TBL] [Abstract][Full Text] [Related]
10. Imaging Cancer-Associated Fibroblasts (CAFs) with FAPi PET.
Gilardi L; Airò Farulla LS; Demirci E; Clerici I; Omodeo Salè E; Ceci F
Biomedicines; 2022 Feb; 10(3):. PubMed ID: 35327325
[TBL] [Abstract][Full Text] [Related]
11. Update on the secondary cytoreduction in platinum-sensitive recurrent ovarian cancer: a narrative review.
Conte C; Fagotti A; Avesani G; Trombadori C; Federico A; D'Indinosante M; Giudice MT; Pelligra S; Lodoli C; Marchetti C; Ferrandina G; Scambia G; Gallotta V
Ann Transl Med; 2021 Mar; 9(6):510. PubMed ID: 33850907
[TBL] [Abstract][Full Text] [Related]
12. Surgery
Capozzi VA; Rosati A; Turco LC; Sozzi G; Riccò M; Chiofalo B; Vizzielli G
Gland Surg; 2020 Aug; 9(4):1112-1117. PubMed ID: 32953626
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of cisplatin during open and minimally-invasive secondary cytoreductive surgery plus HIPEC in women with platinum-sensitive recurrent ovarian cancer: a prospective study.
Petrillo M; Zucchetti M; Cianci S; Morosi L; Ronsini C; Colombo A; D'Incalci M; Scambia G; Fagotti A
J Gynecol Oncol; 2019 Jul; 30(4):e59. PubMed ID: 31074245
[TBL] [Abstract][Full Text] [Related]
14. The Role of
Cengiz A; Koç ZP; Özcan Kara P; Yürekli Y
Mol Imaging Radionucl Ther; 2019 Mar; 28(1):8-14. PubMed ID: 30942056
[TBL] [Abstract][Full Text] [Related]
15. The ability of whole-body SUVmax in F-18 FDG PET/CT to predict suboptimal cytoreduction during primary debulking surgery for advanced ovarian cancer.
Chong GO; Jeong SY; Lee YH; Lee HJ; Lee SW; Han HS; Hong DG; Lee YS
J Ovarian Res; 2019 Feb; 12(1):12. PubMed ID: 30717813
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of
Kim SJ; Lee SW
Br J Radiol; 2018 Jan; 91(1081):20170519. PubMed ID: 29099613
[TBL] [Abstract][Full Text] [Related]
17. Current Recommendations for Minimally Invasive Surgical Staging in Ovarian Cancer.
Fagotti A; Perelli F; Pedone L; Scambia G
Curr Treat Options Oncol; 2016 Jan; 17(1):3. PubMed ID: 26739150
[TBL] [Abstract][Full Text] [Related]
18. Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience.
Gallotta V; Fagotti A; Fanfani F; Ferrandina G; Nero C; Costantini B; Gueli Alletti S; Chiantera V; Ercoli A; Scambia G
Surg Endosc; 2014 Jun; 28(6):1808-15. PubMed ID: 24414460
[TBL] [Abstract][Full Text] [Related]
19. Role of minimally invasive surgery in staging of ovarian cancer.
Iglesias DA; Ramirez PT
Curr Treat Options Oncol; 2011 Sep; 12(3):217-29. PubMed ID: 21503633
[TBL] [Abstract][Full Text] [Related]
20. Imaging ovarian cancer and peritoneal metastases--current and emerging techniques.
Kyriazi S; Kaye SB; deSouza NM
Nat Rev Clin Oncol; 2010 Jul; 7(7):381-93. PubMed ID: 20386556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
